VR technology provides surgical teams with additional insight and provides a more effective game plan.

Magnetic resonance imaging (MRI) is a technology that has been around for more than four decades and is a staple in healthcare. Like other long-established technologies, there have been ongoing improvements to MRI scans.

May 1, 2023 — Medtronic plc, a global leader in healthcare technology, announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. 

May 1, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that the first carotid artery disease patient has been treated utilizing CGuard Prime,

Top 10 articles viewed in April 2023 on dicardiology.com

As we head into Spring, let's take a look at the Top 10 topics that viewers were reading about during the month of April.

1. Atrial Fibrillation Market Reaches $20.92B, According to New Report

2. BLOG: Making a Case for the Variable Rate Contrast Injector

April 28, 2023 — A long-term analysis designed by Christian Gerges and Irene Lang at the Department of Medicine II of the University Hospital Vienna and MedUni Vienna indicates that one third of patients with chronic thromboembolic pulmonary hypertension (CTEPH) also have left heart disease.

April 28, 2023 — Windtree Therapeutics, Inc. is a biotechnology company focused on advancing late-stage interventions for acute cardiovascular disorders of acute heart failure and a lead program studying istaroxime in cardiogenic shock. Cardiogenic shock is caused by a failing heart resulting in diminished cardiac output to the body and is characterized by very low blood pressure and hypoperfusion to end-organs.

April 28, 2023 — Medtronic today shared additional 36-month data from the IN.PACT AV Access Study, as well as 48-month vital status outcomes.

April 27, 2023 — New research suggests that even mild cases of COVID-19 can have long-term detrimental effects on cardiovascular health.  

April 27, 2023 — Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been granted FDA Breakthrough Device Status for its AI-enhanced platform for detecting cardiac amyloidosis. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now